查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449254

全球口腔黏膜药物市场：份额、规模、趋势、行业分析报告 - 按产品类型、给药途径、适应症、分销管道、地区和细分市场预测，2024-2032 年

Oral Transmucosal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Tablets, Films), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

预计2032年，全球口腔黏膜药物市场规模将达到829.9亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

研发工作的激增，加上新产品的推出和目标疾病盛行率的增加，必将推动市场成长。 此外，目标人群的增加预计将有助于市场扩张。 口服经黏膜芬太尼柠檬酸盐的独特配方将芬太尼融入含片中，通过颊黏膜输送药物，与口服途径相比，通过绕过首过代谢提高了生物利用度。

因此，寻求立即缓解各种疾病相关疼痛的患者群体对阿片类药物的依赖性不断增加，可能会推动对口腔黏膜药物的需求。 例如，根据世界卫生组织 2021 年的数据，全球约有 2.75 亿人使用毒品，其中约 6,200 万人使用鸦片类药物。

帕金森氏症 (PD) 和偏头痛盛行率的增加预计将推动市场扩张。 例如，根据帕金森氏症基金会2022年1月发布的数据，美国目前约有1,000万人患有帕金森氏症，预计到2030年将增加至约120万人。 帕金森氏症是继阿兹海默症之后第二常见的神经退化性疾病，每年有超过 60,000 名美国人被诊断出患有帕金森氏症。 此类疾病的日益普及可能会推动使用口腔黏膜药物进行治疗，从而改善疼痛管理并立即缓解疼痛。

根据CDC 数据，截至2021 年1 月，美国65 岁及以上的成年人中有26% 拥有八颗或更少的牙齿，而同年龄层的成年人中约有六分之一(17 %) 的牙齿已全部失去。他的牙齿。 此外，根据 2022 年 2 月 CDC 数据，美国 18 岁以上成年人中有 63% 在过去一年看过牙医，2020 年 2 至 17 岁儿童中有 85.9% 曾看过牙医。考试。 牙科就诊次数的增加预计将推动对用于镇静和镇痛的口腔黏膜药物（例如咪达唑仑和丁丙诺啡）的需求。

口腔黏膜药物市场报告重点

片剂由于易于使用、易于吸收、效率高而占据最大的市场份额

阿片类药物成瘾正在占领市场，这主要是由于阿片类药物疾病的增加。

舌下含服药是治疗急性疼痛的首选，市占率最大

由于亚太地区大量人口遭受压力和精神问题，预计该地区将以最快的速度增长。

市场参与者包括 Aquestive Therapeutics、C.L. Pharm、GW Pharmaceuticals、IntelGenx、辉瑞、Seoul Pharmaceuticals 和 Shilpa Therapeutics。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球口腔黏膜药物市场洞察

  • 口腔黏膜药物 - 产业概况
  • 口腔黏膜药物市场动态
    • 推动者和机会
      • 越来越多地在医疗保健领域使用口腔黏膜药物技术
      • 技术进步
    • 抑制因素和挑战
      • 日益数位化限制了市场成长
  • 杵分析
  • 口腔黏膜药物产业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球口腔黏膜药物市场：依产品类型

  • 主要发现
  • 简介
  • 平板电脑
  • 电影
  • 液体/喷雾
  • 其他

第6章全球口腔黏膜药物市场：依给药途径划分

  • 主要发现
  • 简介
  • 舌下黏膜
  • 其他

第7章全球口腔黏膜药物市场：依适应症划分

  • 主要发现
  • 简介
  • 阿片类药物依赖
  • 噁心和呕吐
  • 勃起功能障碍
  • 神经系统疾病
  • 其他

第 8 章全球口腔黏膜药物市场：依通路划分

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章全球口腔黏膜药物市场：按地区

  • 主要发现
  • 简介
    • 口腔黏膜药物市场评估：按地区（2019-2032）
  • 口腔黏膜药物市场 - 北美
    • 依产品类型划分（2019-2032）
    • 依通路划分（2019-2032）
    • 依给药途径（2019-2032）
    • 依指示（2019-2032）
    • 美国
    • 加拿大
  • 口腔黏膜药物市场 - 欧洲
    • 依产品类型划分（2019-2032）
    • 依通路划分（2019-2032）
    • 依给药途径（2019-2032）
    • 依指示（2019-2032）
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 口腔黏膜药物市场 - 亚太地区
    • 依产品类型划分（2019-2032）
    • 依通路划分（2019-2032）
    • 依给药途径（2019-2032）
    • 依指示（2019-2032）
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 口腔黏膜药物市场 - 中东和非洲
    • 依产品类型划分（2019-2032）
    • 依通路划分（2019-2032）
    • 依给药途径（2019-2032）
    • 依指示（2019-2032）
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯联合大公国
  • 口腔黏膜药物市场 - 拉丁美洲
    • 依产品类型划分（2019-2032）
    • 依通路划分（2019-2032）
    • 依给药途径（2019-2032）
    • 依指示（2019-2032）
    • 墨西哥
    • 巴西
    • 阿根廷

第10章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第11章公司简介

  • Aquestive Therapeutics, Inc
  • C.L.Pharm Co., Ltd
  • GW Pharmaceuticals plc
  • IntelGenx Corp
  • IntelGenx Corp
  • Pfizer Inc
  • Seoul Pharmaceuticals
  • Shilpa Therapeutics
  • Sunovion Pharmaceuticals, Inc.
  • ZIM Laboratories Limited
Product Code: PM4439

The global oral transmucosal drugs market size is expected to reach USD 82.99 billion by 2032, according to a new study by Polaris Market Research. The report "Oral Transmucosal Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Tablets, Films), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surge in research and development endeavors, coupled with new product launches and an increase in the prevalence of targeted diseases, is poised to propel market growth. Additionally, the growth in the target population is expected to contribute to the market's expansion. The unique formulation of oral transmucosal fentanyl citrate, incorporating fentanyl in a lozenge for drug delivery through the buccal mucosa, offers enhanced bioavailability compared to the oral route by bypassing first-pass metabolism.

Consequently, the growing opioid dependence within the patient population seeking immediate relief from pain associated with various disorders is likely to drive the demand for oral transmucosal drugs, for example, as per the World Health Organization's data from 2021, around 275 million people globally used medications, with approximately 62 million among them using opioids.

The growing prevalence of Parkinson's disease (PD) and migraine is anticipated to drive the expansion of the market. For instance, data from the Parkinson's Foundation, January 2022, reveals that nearly one million people in the United States are currently living with Parkinson's disease, with projections indicating an increase to around 1.2 Mn by 2030. Parkinson's disease stands as the second-most common neurodegenerative disease, following Alzheimer's disease, with over 60,000 Americans diagnosed annually and a global population exceeding 10 Mn individuals living with PD. The rising incidences of such disorders are likely to boost the adoption of oral transmucosal drugs for their treatment, leading to improved pain management and immediate relief.

As of January 2021, data from the CDC indicates that 26% of adults aged 65 or older had eight or fewer teeth, and approximately 1 in 6 (17%) adults in the same age group had lost all their teeth in the United States. Additionally, according to CDC data from February 2022, 63% of adults aged 18 and over in the United States had a dental visit in the past year, and 85.9% of children aged 2-17 years had a dental visit in the year 2020. This rise in dental visits is expected to fuel the demand for oral transmucosal drugs, such as midazolam and buprenorphine, for sedation and pain relief.

Oral Transmucosal Drugs Market Report Highlights

Tablets segment held the largest share, owing to its ease of use, easy absorption, and have higher efficiency

Opioid dependence segment dominated the market, primarily due to rising cases of opioid disorders

Sub-lingual drugs garnered the largest share, as they are mostly preferred during acute pain conditions

APAC expected to grow at the fastest rate, due to presence of huge population suffering with stress and mental conditions

The market players include Aquestive Therapeutics, C.L. Pharm, GW Pharmaceuticals, IntelGenx, Pfizer, Seoul Pharmaceuticals, and Shilpa Therapeutics

Polaris Market Research has segmented the oral transmucosal drugs market report based on product type, route of administration, indication, distribution channel, and region:

Oral Transmucosal Drugs, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tablets
  • Films
  • Liquid & Spray
  • Others

Oral Transmucosal Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Sublingual Mucosa
  • Buccal Mucosa
  • Others

Oral Transmucosal Drugs, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid Dependence
  • Nausea and Vomiting
  • Erectile Dysfunction
  • Neurological Disorders
  • Others

Oral Transmucosal Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Oral Transmucosal Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Oral Transmucosal Drugs Market Insights

  • 4.1.Oral Transmucosal Drugs - Industry Snapshot
  • 4.2.Oral Transmucosal Drugs Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Increasing use of Oral Transmucosal Drugs technology in healthcare
      • 4.2.1.2.Technological advancement
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.Increasing digitization will restrict the market growth
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Oral Transmucosal Drugs Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Oral Transmucosal Drugs Market, by Product Distribution Channel

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • 5.3.Tablets
    • 5.3.1.Global Oral Transmucosal Drugs Market, by Tablets, by Region, 2019-2032 (USD Billion)
  • 5.4.Films
    • 5.4.1.Global Oral Transmucosal Drugs Market, by Films, by Region, 2019-2032 (USD Billion)
  • 5.5.Liquid & Spray
    • 5.5.1.Global Oral Transmucosal Drugs Market, by Liquid & Spray, by Region, 2019-2032 (USD Billion)
  • 5.6.Others
    • 5.6.1.Global Oral Transmucosal Drugs Market, by Others , by Region, 2019-2032 (USD Billion)

6.Global Oral Transmucosal Drugs Market, by Route of Administration

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3.Sublingual Mucosa
    • 6.3.1.Global Oral Transmucosal Drugs Market, by Sublingual Mucosa, by Region, 2019-2032 (USD Billion)
  • 6.4.Sublingual Mucosa
    • 6.4.1.Global Oral Transmucosal Drugs Market, by Sublingual Mucosa, by Region, 2019-2032 (USD Billion)
  • 6.5.Others
    • 6.5.1.Global Oral Transmucosal Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Oral Transmucosal Drugs Market, by Indication

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 7.3.Opioid Dependence
    • 7.3.1.Global Oral Transmucosal Drugs Market, by Opioid Dependence, by Region, 2019-2032 (USD Billion)
  • 7.4.Nausea and Vomiting
    • 7.4.1.Global Oral Transmucosal Drugs Market, by Nausea and Vomiting, by Region, 2019-2032 (USD Billion)
  • 7.5.Erectile Dysfunction
    • 7.5.1.Global Oral Transmucosal Drugs Market, by Erectile Dysfunction, by Region, 2019-2032 (USD Billion)
  • 7.6.Neurological Disorders
    • 7.6.1.Global Oral Transmucosal Drugs Market, by Neurological Disorders, by Region, 2019-2032 (USD Billion)
  • 7.7.Others
    • 7.7.1.Global Oral Transmucosal Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Oral Transmucosal Drugs Market, by Distribution Channel

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3.Hospital Pharmacies
    • 8.3.1.Global Oral Transmucosal Drugs Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4.Retail Pharmacies
    • 8.4.1.Global Oral Transmucosal Drugs Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.5.Online Pharmacies
    • 8.5.1.Global Oral Transmucosal Drugs Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9.Global Oral Transmucosal Drugs Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Oral Transmucosal Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Oral Transmucosal Drugs Market - North America
    • 9.3.1.North America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.2.North America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.3.North America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.4.North America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.5.Oral Transmucosal Drugs Market - U.S.
      • 9.3.5.1.U.S.: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.6.Oral Transmucosal Drugs Market - Canada
      • 9.3.6.1.Canada: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.4.Oral Transmucosal Drugs Market - Europe
    • 9.4.1.Europe: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.5.Oral Transmucosal Drugs Market - UK
      • 9.4.5.1.UK: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.6.Oral Transmucosal Drugs Market - France
      • 9.4.6.1.France: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.7.Oral Transmucosal Drugs Market - Germany
      • 9.4.7.1.Germany: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.8.Oral Transmucosal Drugs Market - Italy
      • 9.4.8.1.Italy: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.9.Oral Transmucosal Drugs Market - Spain
      • 9.4.9.1.Spain: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.10.Oral Transmucosal Drugs Market - Netherlands
      • 9.4.10.1.Netherlands: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.11.Oral Transmucosal Drugs Market - Russia
      • 9.4.11.1.Russia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.5.Oral Transmucosal Drugs Market - Asia Pacific
    • 9.5.1.Asia Pacific: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.5.Oral Transmucosal Drugs Market - China
      • 9.5.5.1.China: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.6.Oral Transmucosal Drugs Market - India
      • 9.5.6.1.India: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.7.Oral Transmucosal Drugs Market - Japan
      • 9.5.7.1.Japan: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.8.Oral Transmucosal Drugs Market - Malaysia
      • 9.5.8.1.Malaysia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.9.Oral Transmucosal Drugs Market - Indonesia
      • 9.5.9.1.Indonesia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.10.Oral Transmucosal Drugs Market - South Korea
      • 9.5.10.1.South Korea: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.6.Oral Transmucosal Drugs Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.5.Oral Transmucosal Drugs Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.6.Oral Transmucosal Drugs Market - South Africa
      • 9.6.6.1.South Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.7.Oral Transmucosal Drugs Market - Israel
      • 9.6.7.1.Israel: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.8.Oral Transmucosal Drugs Market - UAE
      • 9.6.8.1.UAE: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • 9.7.Oral Transmucosal Drugs Market - Latin America
    • 9.7.1.Latin America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.5.Oral Transmucosal Drugs Market - Mexico
      • 9.7.5.1.Mexico: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.6.Oral Transmucosal Drugs Market - Brazil
      • 9.7.6.1.Brazil: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.7.Oral Transmucosal Drugs Market - Argentina
      • 9.7.7.1.Argentina: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Aquestive Therapeutics, Inc
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.C.L.Pharm Co., Ltd
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.GW Pharmaceuticals plc
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.IntelGenx Corp
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.IntelGenx Corp
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Pfizer Inc
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Seoul Pharmaceuticals
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.Shilpa Therapeutics
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Sunovion Pharmaceuticals, Inc.
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.ZIM Laboratories Limited
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development

List of Tables

  • Table 1 Global Oral Transmucosal Drugs Market, by Product Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Oral Transmucosal Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Oral Transmucosal Drugs Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Oral Transmucosal Drugs Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Oral Transmucosal Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 North America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 U.S.: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 U.S.: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 13 U.S.: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 Canada: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Canada: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 17 Canada: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 Europe: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 20 Europe: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 Europe: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Germany: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 France: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 27 France: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 France: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 29 France: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 UK: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 32 UK: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 UK: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Italy: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Italy: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 37 Italy: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 Spain: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Spain: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Spain: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Russia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Russia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 49 Russia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 54 China: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 China: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 56 China: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 China: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Japan: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Japan: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 61 Japan: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 India: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 63 India: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 India: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 India: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 75 South Korea: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 South Korea: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 77 South Korea: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Latin America: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 80 Latin America: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Latin America: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Brazil: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Brazil: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Brazil: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 87 Mexico: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Mexico: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 89 Mexico: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 Argentina: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 92 Argentina: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 93 Argentina: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 99 UAE: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 100 UAE: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 101 UAE: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 107 South Africa: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 South Africa: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 109 South Africa: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Oral Transmucosal Drugs Market, by Product Distribution Channel, 2019-2032 (USD Billion)
  • Table 111 Israel: Oral Transmucosal Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 112 Israel: Oral Transmucosal Drugs Market, by Indication, 2019-2032 (USD Billion)
  • Table 113 Israel: Oral Transmucosal Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oral Transmucosal Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Distribution Channel
  • Figure 7. Global Oral Transmucosal Drugs Market, by Product Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Oral Transmucosal Drugs Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Oral Transmucosal Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Oral Transmucosal Drugs Market, by Indication, 2021 & 2030 (USD Billion)